Global Corneal Blindness and the Boston Keratoprosthesis Type I

American Journal of Ophthalmology

Volumn 149, Issue 4, 2010, Pages 537-539

  Ament, Jared D ^a   Todani, Amit ^a   Pineda II, Roberto ^a   Shen, Tueng T ^b   Aldave, Anthony J ^c   Dohlman, Claes H ^a   Chodosh, James ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOTRANSPLANTATION; CORNEA TRANSPLANTATION; CORNEAL BLINDNESS; EDITORIAL; GLAUCOMA; HUMAN; KERATOPROSTHESIS; PRIORITY JOURNAL; VISUAL ACUITY; VISUAL IMPAIRMENT; VITREOUS DISEASE;

ARTIFICIAL ORGANS; BLINDNESS; CORNEA; CORNEAL DISEASES; CORNEAL TRANSPLANTATION; DEVELOPING COUNTRIES; GRAFT SURVIVAL; HUMANS; INCIDENCE; PROSTHESES AND IMPLANTS; PROSTHESIS IMPLANTATION; TRANSPLANTATION, HOMOLOGOUS; VISUALLY IMPAIRED PERSONS; WORLD HEALTH;

EID: 77949629414     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2009.11.001     Document Type: Editorial

References (14)

1. World Health Organization. Visual impairment and blindness. http://www.who.int/mediacentre/factsheets/fs282/en/ Accessed August 20, 2009
2. Whitcher J.P., Srinivasan M., and Upadhyay M.P. Bull World Health Org 79 (2001) 214-221
3. Upadhyay M.P., Karmacharya P.C., Koirala S., et al. The Bhaktapur eye study: ocular trauma and antibiotic prophylaxis for the prevention of corneal ulceration in Nepal. Br J Ophthalmol 85 (2001) 388-392
4. World Health Organization. Global initiative for the elimination of avoidable blindness (Unpublished document WHO/PBL/97.61/Rev 1) (1997), World Health Organization, Prevention of Blindness and Deafness, Geneva. http://whqlibdoc.who.int/hq/1997/WHO_PBL_97.61_Rev.1.pdf Accessed August 20, 2009
5. Raychaudhuri A., Raychaudhuri M., and Banerjee A.R. Availability of donor corneal tissue for transplantation. Trop Doct 34 (2004) 99-101
6. Dohlman C.H. Guillaume Pellier. In: Mannis M.J., and Mannis A.A. (Eds). Corneal Transplantation: A History in Profiles (Hirschberg History of Ophthalmology) (1999), JP Wayenborgh, Oostende, Belgium 53-64
7. Dohlman C.H., Harissi-Dagher M., Khan B.F., Sippel K., Aquavella J.V., and Graney J.M. Introduction to the use of the Boston keratoprosthesis. Expert Rev Ophthalmol 1 (2006) 41-48
8. Massachusetts Eye and Ear Infirmary. Boston keratoprosthesis update (2009), Newsletter VI. http://www.kpro.org/wp-content/uploads/2009/09/2009-kpro-newsletter-pdf.pdf Accessed February 21, 2010
9. Zerbe B.L., Belin M.W., and Ciolino J.B. Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology 113 (2006) 1779e1-1779e7
10. Aldave A.J., Kamal K.M., Vo R.C., and Yu F. The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology 116 (2009) 640-651
11. Dohlman C., Dudenhoefer E., Khan B.F., and Morneault S. Protection of the ocular surface after keratoprosthesis surgery: the role of soft contact lenses. CLAO J 28 (2002) 72-74
12. Bersudsky V., Blum-Hareuveni T., Rehany U., and Rumelt S. The profile of repeated corneal transplantation. Ophthalmology 108 (2001) 461-469
13. Ament J.D., Pineda R., Lawson B., Behlau I., and Dohlman C.H. The Boston keratoprosthesis: international protocol. Version 2 (June 15, 2009). http://www.masseyeandear.org/gedownload!/KPro%20International%20Protoc012.pdf?item_id=5816015&version_id=5816016 Accessed August 20, 2009
14. Ament J.D., Stryjewski T.P., Ciolino J.B., Todani A., Chodosh J., and Dohlman C.H. Cost-Effectiveness of the Boston Keratoprosthesis. Am J Ophthalmol 149 (2010) 221-228